Anti-GBM antibodies co-exist with MPO-ANCA in a 4-year-old girl with acute renal failure.
Naidoo
Sarveshni
S
Waller
Simon
S
D058186:Acute Kidney Injury / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D019867:Anti-Glomerular Basement Membrane Disease / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D050533:Glomerular Basement Membrane / Q000276:immunology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007275:Injections, Intravenous; D007668:Kidney / Q000473:pathology; D007678:Kidney Glomerulus / Q000276:immunology / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D009195:Peroxidase / Q000276:immunology*; D011239:Prednisolone / Q000627:therapeutic use; D016896:Treatment Outcome
D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; D007166:Immunosuppressive Agents; C051951:antiglomerular basement membrane antibody; D003520:Cyclophosphamide; D011239:Prednisolone; D009195:Peroxidase; D008775:Methylprednisolone